It's our migraine and headache news episode. Lindsay Weitzel, PhD, sits down with NHF board member and clinical trial researcher Tim Smith, MD, to walk through the latest research.
They cover a French study linking some COVID vaccines with new or returning cluster headache. They look at long-term data showing weight loss in some people taking atogepant for migraine prevention. They discuss a new analysis of the Women's Health Initiative on hormone replacement therapy and migraine, a press release on a botulinum toxin for both episodic and chronic migraine, and the new migraine prevention guidelines from the American Headache Society and the American Academy of Neurology.
This episode is for educational purposes only and is not medical advice. Talk with your healthcare provider about your symptoms and treatment.
Mais episódios de "HeadWise"



Não percas um episódio de “HeadWise” e subscrevê-lo na aplicação GetPodcast.








